However, further clinical trials and prospective cohort studies are needed to elucidate the role of AGEs and TXNIP in the occurrence of heterotopic renal fat deposition and diabetes-related complications in patients with T2DM. The gene discussed is TXNIP; the disease is diabetes mellitus.